The Quantellect read.As of Nov 19, 2026, 21 active firms cover The Allstate Corporation: 8 rate it Buy or better, 10 sit at Neutral, and 3 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $215.00 to $300.00, so the covering firms are broadly aligned. The average target of $259.78 sits 3% below the current $266.55. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees revenue growth near 4% this year and 4% next, consensus EPS building from about $8.34 next quarter toward $28.51 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS21 active firms
Neutral
Strong Buy15%
Buy733%
Neutral1048%
Sell314%
Strong Sell00%
Based on 21 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$259.78
-2.5% downside
Average target across 18 active firms as of Nov 19, 2026 vs $266.55 current
Highest Target$300.00
Average Target$259.78
Lowest Target$215.00
Detailed analyst forecasts for ALL
Showing 1–21 of 21 named analysts shown · 21 active firms in the rating projection
As of Nov 19, 2026, 8 of 21 active firms rate ALL a Buy (10 Neutral, 3 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ALL EPS & revenue forecast
EPS · NEXT QUARTER
$8.34
Range $6.55 – $10.47 · 18 analysts · -22% YoY
Next period, 18 analysts expect The Allstate Corporation to earn $8.34 a share (range $6.55 – $10.47), versus $10.65 a year earlier. Full-year consensus is $38.90, growing to $28.51 the year after.
REVENUE · NEXT QUARTER
$17.7B
Range $17.1B – $18.0B · 18 analysts · +2% YoY
Revenue is expected to reach $17.7B (range $17.1B – $18.0B), +2.0% year-over-year. Full-year consensus is $70.3B, rising to $72.7B next year.
Top analysts covering The Allstate Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ALL.
#1
Alex Scott
Barclays · Rank #38
Sell
$228.00-14.5% to target
Overall win rate
58%
+ Follow
#2
Elyse Greenspan
Wells Fargo · Rank #85
Neutral
$236.00-11.5% to target
Overall win rate
57%
+ Follow
#3
C. Gregory Peters
Raymond James · Rank #240
Buy
$315.00+18.2% to target
Overall win rate
52%
+ Follow
#4
Meyer Shields
Keefe, Bruyette & Woods · Rank #259
Sell
$232.00-13.0% to target
Overall win rate
44%
+ Follow
#5
Paul Newsome
Piper Sandler · Rank #272
Buy
$300.00+12.5% to target
Overall win rate
50%
+ Follow
ALL stock forecast FAQ
What is ALL's average 12-month price target?+
The 18 active firms with a live target average $259.78 for The Allstate Corporation over the next 12 months, ranging from a $300.00 high to a $215.00 low, as of Nov 19, 2026.
Is ALL stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 21 active firms as of Nov 19, 2026, 8 rate it Buy or Strong Buy, 10 rate it Neutral, and 3 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ALL?+
The Street-high target is $300.00 (Piper Sandler), and the Street-low is $215.00 (Citigroup). The average of all 18 active-firm targets is $259.78.
How many active Wall Street firms cover ALL?+
21 active firms have a recognized rating on The Allstate Corporation as of Nov 19, 2026, and 18 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ALL?+
Among analysts who currently cover ALL, Alex Scott of Barclays has the strongest overall Quantellect track record (Rank #38). Their current call is Sell with a $228.00 target.
What is The Allstate Corporation's projected EPS for next quarter?+
The consensus estimate is $8.34 per share (range $6.55 – $10.47) across 18 analysts. Full-year EPS is projected at $38.90, rising to $28.51 the following year.
How much revenue is The Allstate Corporation expected to report next quarter?+
Consensus revenue is $17.7B (range $17.1B – $18.0B). Full-year revenue is projected at $70.3B, growing to $72.7B next year.
Have analysts been upgrading or downgrading ALL lately?+
As of Nov 19, 2026, 8 of 21 active firms rate ALL a Buy (10 Neutral, 3 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ALL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.